CFDE Data Portal | Search MIR3648-2

	Label	Description
	MIR3648-2 Gene (Entity type)	ENSG00000264462 - microRNA 3648-2
	GSE119369 H10 inhibition 3 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE155162 GSE155169 buparlisib 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE147876 GSE147877 enzalutamide MR42D 4 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE238116 EGR1 HCC overexpression MHCC97-H PLC-PRF-5 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE217552 fisetin 3 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE206226 cisplatin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 paclitaxel 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE174745 dopamine neuron 1 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS

MIR3648-2

ENSG00000264462 - microRNA 3648-2

GSE119369 H10 inhibition 3 v 7 human dn

A Gene Set from LINCS

GSE155162 GSE155169 buparlisib 1 v 3 human dn

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human up

A Gene Set from LINCS

GSE147876 GSE147877 enzalutamide MR42D 4 v 7 human up

A Gene Set from LINCS

GSE238116 EGR1 HCC overexpression MHCC97-H PLC-PRF-5 1 v 2 human up

A Gene Set from LINCS

GSE217552 fisetin 3 v 4 human up

A Gene Set from LINCS

GSE206226 cisplatin 0 v 1 human up

A Gene Set from LINCS

GSE172016 paclitaxel 2 v 1 human dn

A Gene Set from LINCS

GSE174745 dopamine neuron 1 v 8 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.